Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Soul Pattinson Manufacturing Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (204)
ARTG (42)
Cancellation or suspension (11)
Listed medicine compliance report (4)

Date

2026 (27)
2025 (39)
2024 (41)
2023 (8)
2022 (30)
2021 (26)
2020 (62)
2019 (11)
2018 (4)
2017 (13)

Search

Sponsor content

261 result(s) found, displaying 111 to 120

MEDCO Paracetamol 500 and Codeine Phosphate 15 paracetamol 500 mg and codeine phosphate hemihydrate 15 mg tablets blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2023

Cancellation by sponsor

Requested by Soul Pattinson Manufacturing Pty Ltd
MEDCO PARACETAMOL 500 CODEINE PHOSPHATE 10 AND DOXYLAMINE SUCCINATE 5.1 tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2023

Cancellation by sponsor

Requested by Soul Pattinson Manufacturing Pty Ltd
MEDCO IBUPROFEN 200 and CODEINE PHOSPHATE 12.8 ibuprofen 200 mg and codeine phosphate hemihydrate 12.8 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2023

Cancellation by sponsor

Requested by Soul Pattinson Manufacturing Pty Ltd
PRICELINE PHARMACY DRY COUGH RELIEF FORTE pholcodine 4 mg/mL oral liquid bottle (Cancellation from the ARTG under s.30(2)(a) of the Act)

29 March 2023

Cancellation or suspension

Regulatory action due to the product appearing to the Secretary that the quality, safety or efficacy of the goods was unacceptable, effective 29/03/2023
PHARMACY HEALTH DRY COUGH RELIEF FORTE pholcodine 4 mg/mL oral liquid bottle (Cancellation from the ARTG under s.30(2)(a) of the Act)

29 March 2023

Cancellation or suspension

Regulatory action due to the product appearing to the Secretary that the quality, safety or efficacy of the goods was unacceptable, effective 29/03/2023
TERRYWHITE CHEMMART IBUPROFEN 200 MG capsule-shaped tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 September 2022

Cancellation by sponsor

Requested by Soul Pattinson Manufacturing Pty Ltd
TERRYWHITE CHEMMART BISACODYL LAXATIVE 5 mg enteric coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 September 2022

Cancellation by sponsor

Requested by Soul Pattinson Manufacturing Pty Ltd
AMCAL MACROGOL PLUS ELECTROLYTES powder for oral liquid sachet Cancelled under Section 30(1)(c) of the Act

28 September 2022

Cancellation by sponsor

Requested by Soul Pattinson Manufacturing Pty Ltd
PHARMACY HEALTH SENEGA & AMMONIA oral liquid bottle Cancelled under Section 30(1)(c) of the Act

28 September 2022

Cancellation by sponsor

Requested by Soul Pattinson Manufacturing Pty Ltd
PRICELINE PHARMACY DIARRHOEA RELIEF PLUS chewable tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 September 2022

Cancellation by sponsor

Requested by Soul Pattinson Manufacturing Pty Ltd

Pages

First page
Previous page
…
Page 8
Page 9
Page 10
Page 11
Current page 12
Page 13
Page 14
Page 15
Page 16
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.